Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.29% Nasdaq Down0.15%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM

2.64 Down 0.10(3.61%) 2:16PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 5   447   428  
Cost of Revenue -   -   -  
Gross Profit 5   447   428  
Operating Expenses
Research Development8,671  3,796  2,579  
Selling General and Administrative6,374  4,906  2,760  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (15,040) (8,255) (4,910)
Income from Continuing Operations
Total Other Income/Expenses Net3,213  (1,761)801  
Earnings Before Interest And Taxes(11,827)(10,014)(4,293)
Interest Expense505  14  38  
Income Before Tax(12,332)(10,028)(4,331)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(12,332)(10,030)(4,147)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (12,332) (10,030) (4,147)
Preferred Stock And Other Adjustments -  (6,693)(132)
Net Income Applicable To Common Shares (12,332) (16,722) (4,278)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.